Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Dietlein

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
EJNMMI Research|June 10, 2015
Characterization of SnO2-based (68)Ge/ (68)Ga generators and (68)Ga-DOTATATE preparations: radionuclide purity, radiochemical yield and long-term constancyFerdinand Sudbrock, Thomas Fischer, Beate Zimmermanns, et al.
Nuclear Medicine Communications|September 13, 2013
18F-fluorodeoxyglucose uptake pattern in patients with suspected spondylodiscitisStefan Hungenbach, Karl-Stefan Delank, Markus Dietlein, et al.
International Journal of Molecular Sciences|January 28, 2026
Airborne Radioiodine: A Comparative View of Chemical Forms in Medicine, Nuclear Industry, and Fallout ScenariosKlaus Schomäcker, Ferdinand Sudbrock, Thomas Fischer, et al.
Thyroid : Official Journal of the American Thyroid Association|July 18, 2008
Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto's thyroiditis) treated with levothyroxineMatthias Schmidt, Michael Voell, Ilka Rahlff, et al.
Nuclear Medicine Communications|April 22, 2009
Radioiodine therapy for thyroid volume reduction of large goitresJuliane Bachmann, Carsten Kobe, Seher Bor, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 18, 2011
Exhalation of ¹³¹I after radioiodine therapy: measurements in exhaled airKlaus Schomäcker, Ferdinand Sudbrock, Thomas Fischer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2018
Thyroid Uptake and Effective Half-Life of Radioiodine in Thyroid Cancer Patients at Radioiodine Therapy and Follow-Up Whole-Body Scintigraphy Either in Hypothyroidism or Under rhTSHRobin Bacher, Melanie Hohberg, Markus Dietlein, et al.
Nuclear Medicine Communications|October 7, 2005
Stability of radioactive colloids for radiation synovectomy: influence of X-ray contrast agents, anaesthetics and glucocorticoids in vitroKlaus Schomäcker, Markus Dietlein, Gynter Mödder, et al.
Nuklearmedizin. Nuclear Medicine|October 14, 2025
Performance of a large language model in lymphoma stage assignment based on written PET/CT reportsConrad-Amadeus Voltin, Jonathan Kottlors, Peter Borchmann, et al.
Onkologie|February 13, 2008
Yttrium-90 ibritumomab tiuxetan-induced complete remission in a patient with classical lymphocyte-rich Hodgkin's LymphomaRoland Schnell, Markus Dietlein, Klaus Schomäcker, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
EJNMMI Research|June 10, 2015
Characterization of SnO2-based (68)Ge/ (68)Ga generators and (68)Ga-DOTATATE preparations: radionuclide purity, radiochemical yield and long-term constancyFerdinand Sudbrock, Thomas Fischer, Beate Zimmermanns, et al.
Nuclear Medicine Communications|September 13, 2013
18F-fluorodeoxyglucose uptake pattern in patients with suspected spondylodiscitisStefan Hungenbach, Karl-Stefan Delank, Markus Dietlein, et al.
International Journal of Molecular Sciences|January 28, 2026
Airborne Radioiodine: A Comparative View of Chemical Forms in Medicine, Nuclear Industry, and Fallout ScenariosKlaus Schomäcker, Ferdinand Sudbrock, Thomas Fischer, et al.
Thyroid : Official Journal of the American Thyroid Association|July 18, 2008
Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto's thyroiditis) treated with levothyroxineMatthias Schmidt, Michael Voell, Ilka Rahlff, et al.
Nuclear Medicine Communications|April 22, 2009
Radioiodine therapy for thyroid volume reduction of large goitresJuliane Bachmann, Carsten Kobe, Seher Bor, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 18, 2011
Exhalation of ¹³¹I after radioiodine therapy: measurements in exhaled airKlaus Schomäcker, Ferdinand Sudbrock, Thomas Fischer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2018
Thyroid Uptake and Effective Half-Life of Radioiodine in Thyroid Cancer Patients at Radioiodine Therapy and Follow-Up Whole-Body Scintigraphy Either in Hypothyroidism or Under rhTSHRobin Bacher, Melanie Hohberg, Markus Dietlein, et al.
Nuclear Medicine Communications|October 7, 2005
Stability of radioactive colloids for radiation synovectomy: influence of X-ray contrast agents, anaesthetics and glucocorticoids in vitroKlaus Schomäcker, Markus Dietlein, Gynter Mödder, et al.
Nuklearmedizin. Nuclear Medicine|October 14, 2025
Performance of a large language model in lymphoma stage assignment based on written PET/CT reportsConrad-Amadeus Voltin, Jonathan Kottlors, Peter Borchmann, et al.
Onkologie|February 13, 2008
Yttrium-90 ibritumomab tiuxetan-induced complete remission in a patient with classical lymphocyte-rich Hodgkin's LymphomaRoland Schnell, Markus Dietlein, Klaus Schomäcker, et al.
Pageof 14